Benzodiazepine Derivatives as Potent Vasopressin V<sub>2</sub> Receptor Antagonists for the Treatment of Autosomal Dominant Kidney Disease-Reference-Cited by-同舟云学术

Benzodiazepine Derivatives as Potent Vasopressin V₂ Receptor Antagonists for the Treatment of Autosomal Dominant Kidney Disease

Published:2022-05-17 Issue:13 Volume:65 Page:9295-9311
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Cao Xudong¹,Wang Peng¹,Yuan Haoxing¹,Zhang Haoran¹,He Yan¹,Fu Kequan¹,Fang Qian²,Liu Hongli¹,Su Limin¹,Yin Long¹,Xu Pei¹,Xie Yuyang¹,Xiong Xiaochun¹,Wang Junqi²,Zhu Xu¹,Guo Dong¹^ORCID

Affiliation:

1. Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, 209 Tongshan Road, Xuzhou 221004, Jiangsu, China

2. The Affiliated Hospital of Xuzhou Medical University, No. 99 Huaihai West Road, Xuzhou 221002, China

Funder

Natural Science Foundation of Jiangsu Province

Major Basic Research Project of the Natural Science Foundation of the Jiangsu Higher Education Institutions

National Natural Science Foundation of China

Youth Foundation of Xuzhou Medical University

Science and Technology Project of Xuzhou City

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.2c00567

Reference40 articles.

1. Recent Advances in the Management of Autosomal Dominant Polycystic Kidney Disease

2. Autosomal dominant polycystic kidney disease

3. Polycystic kidney disease

4. Autosomal dominant polycystic kidney disease: Disrupted pathways and potential therapeutic interventions

5. Cyclic AMP-mediated cyst expansion

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structural basis of tolvaptan binding to the vasopressin V2 receptor;Acta Pharmacologica Sinica;2024-06-20

2. Notch3 as a novel therapeutic target for the treatment of ADPKD by regulating cell proliferation and renal cyst development;Biochemical Pharmacology;2024-06

3. Asymmetric synthesis of P-stereogenic phosphindane oxides via kinetic resolution and their biological activity;Nature Communications;2024-03-21

4. Long-Residence Time Peptide Antagonist for the Vasopressin V₂ Receptor to Treat Autosomal Dominant Polycystic Kidney Disease;Journal of Medicinal Chemistry;2024-03-20

5. Target immobilization on glass microfiber membranes as a label-free strategy for hit identification;Analytical and Bioanalytical Chemistry;2023-09-21